To: Environmental Protection Agency
"We were encouraged by the inclusion of several phthalates with endocrine effects on the list of High-Priority Candidates; however, the draft scopes do not adequately describe how EPA will evaluate hazards associated with exposure to these chemicals. In our comments, we identify several improvements to the scoping documents that will allow EPA to conduct a more thorough examination of the endocrine-related effects of these chemicals."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.